Otter Pharms patents expiration
1. Otrexup patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7776015 | OTTER PHARMS | Needle assisted jet injector |
Aug, 2019
(4 years ago) | |
| USRE44846 | OTTER PHARMS | Needle assisted jet injector |
Aug, 2019
(4 years ago) | |
| USRE44847 | OTTER PHARMS | Needle assisted jet injector |
Aug, 2019
(4 years ago) | |
| US7744582 | OTTER PHARMS | Needle assisted jet injector |
Aug, 2019
(4 years ago) | |
| US6746429 | OTTER PHARMS | Needle assisted jet injector |
Apr, 2020
(4 years ago) | |
| US9629959 | OTTER PHARMS | Prefilled syringe jet injector |
Jan, 2026
(1 year, 8 months from now) | |
| US8562564 | OTTER PHARMS | Prefilled syringe jet injector |
Jan, 2026
(1 year, 8 months from now) | |
| US9533102 | OTTER PHARMS | Prefilled syringe jet injector |
Jan, 2026
(1 year, 8 months from now) | |
| US11446441 | OTTER PHARMS | Prefilled syringe injector |
Jan, 2026
(1 year, 8 months from now) | |
| US8021335 | OTTER PHARMS | Prefilled syringe jet injector |
Oct, 2026
(2 years from now) | |
| US11684723 | OTTER PHARMS | Injector safety device |
Mar, 2029
(4 years from now) | |
| US9867949 | OTTER PHARMS | Injector safety device |
Mar, 2029
(4 years from now) | |
| US10709844 | OTTER PHARMS | Injector safety device |
Mar, 2029
(4 years from now) | |
| US8579865 | OTTER PHARMS | Hazardous agent injection system |
Mar, 2030
(5 years from now) | |
| US8480631 | OTTER PHARMS | Hazardous agent injection system |
Mar, 2030
(5 years from now) | |
| US9421333 | OTTER PHARMS | Hazardous agent injection system |
Mar, 2030
(5 years from now) | |
| US8945063 | OTTER PHARMS | Hazardous agent injection system |
Mar, 2030
(5 years from now) | |
| US11497753 | OTTER PHARMS | Hazardous agent injection system |
Mar, 2030
(5 years from now) | |
| US8814834 | OTTER PHARMS | Injector safety device |
May, 2031
(7 years from now) | |
Drugs and Companies using METHOTREXATE ingredient
Market Authorisation Date: 07 November, 2014
Treatment: Subcutaneous injection of methotrexate
Dosage: SOLUTION;SUBCUTANEOUS
OTREXUP family patents
2. Sympazan patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8765167 | OTTER PHARMS | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
Feb, 2024
(2 months ago) | |
| US8603514 | OTTER PHARMS | Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
Apr, 2024
(23 days ago) | |
| US11541002 | OTTER PHARMS | Oral film compositions and dosage forms having precise active dissolution profiles |
Jan, 2040
(15 years from now) | |
Drugs and Companies using CLOBAZAM ingredient
Market Authorisation Date: 01 November, 2018
Treatment: Method of treating seizures
Dosage: FILM;ORAL
SYMPAZAN family patents